Carmine Carpenito, PhD
Head of Research
Dr. Carmine Carpenito is the Head of Research at KBio with over 20 years of academic and industry experience in the immune oncology and cell therapy field. Dr. Carpenito has extensive experience in IO drug development (pharma and biotech) focusing on multiple checkpoint inhibitors, T cell engagers/activators, bispecific antibodies, and myeloid cell modulators. He has also worked in numerous roles related to cell therapy including CAR-T, TILs, iPSCs, and dendritic cell vaccines in academia and in CDMO settings. Dr. Carpenito held research and leadership positions at New York Blood Center, Stelexis Therapeutics, Eli Lilly, Lonza, University of Pennsylvania, and UCLA.